Navigation Links
Crisalix Awarded as a Leading Life Science Company that is Revolutionizing the Medical Industry
Date:12/12/2012

Lausanne, Switzerland (PRWEB) December 12, 2012

Crisalix, amongst “the best-of-the-best at the 2012 European Venture Contest” [Europe Unlimited]

The European Venture Contest (EVC) held in Berlin is the largest meeting point for innovative entrepreneurs in the Information & Communications Technology (ICT), Life Sciences and Cleantech sectors. The EVC plays an important role in finding, evaluating and recognizing world-class innovative companies to accelerate their growth by providing access to top-level international partners, and supporting these global leaders of tomorrow by updating the skill set needed to grow their business successfully.

The EVC brings together over 300 top tier venture investors as well as corporate investors from multinationals such as IBM, Roche, Microsoft, Philips, SAP and more. Through 10 rounds of presentations and shortlisting which took place over one year across the main European countries, from an initial 800+ companies the jury made a final selection of the top 10 companies which included Crisalix as one of the only three Life Science companies offering novel technologies, products and services that are expected to dramatically impact their respective industry over the coming years.

This award from top international investors based on specific criteria related to business potential, product merit, competitive positioning and project profile quality amongst others, confirms Crisalix’s position as a leader and pioneer in the field of Aesthetics. It is recognition for the potential that Crisalix represents today and for the years ahead.

About Crisalix

If you were considering modifying your physical appearance, wouldn’t you be wondering “how could I look after the procedure?” Crisalix is a worldwide leader in easy 3D aesthetic simulations based on standard digital photos which provides an answer to the first and foremost question every aesthetic patient asks their physician. With the first cloud solution and SaaS business model for 3D simulations of aesthetic procedures and plastic surgery, Crisalix brings together the latest advancements in surgical and aesthetic technology, 3D and information technology. Crisalix has already enabled physicians in over 70 countries to increase the care and treatment provided to their patients thanks to its unique 3D simulation technology based on regular 2D photos.

Crisalix has been recommended by The International Confederation for Plastic, Reconstructive, and Aesthetic Surgery (IPRAS) for its contribution to improving the care and treatment of patients around the world seeking aesthetic procedures.

Further information

Patients interested in breast augmentation or aesthetic procedures should schedule a consultation by finding the nearest physician offering Crisalix simulations using the Aesthetic Professional Directory.

Physicians interested in incorporating Crisalix 3D simulations in their aesthetic consultations should directly open an account on: http://crisalix.com/en

Press contacts: Nandan Sampatkumar
Tel: (00 41) 21 693 90 01
Email: press(at)crisalix(dot)com
Website: http://www.crisalix.com

Read the full story at http://www.prweb.com/releases/Crisalix3DSimulations/EVCcontest/prweb10227466.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Plant Sensory Systems Awarded $1.8 Million from ARPA-E to Engineer Beets for Biofuel
2. Ben-Gurion University awarded $6.5 million grant to develop nano thin infrared night vision glasses
3. Arecor Awarded Biomedical Catalyst Funding Towards £1.3 Million Project
4. WaferGen Bio-systems Awarded 1 Million Euro Grant by the Luxembourg Government to expand its European Operations
5. Stanford faculty awarded $2.2 million for innovative energy research
6. CSL Biotherapies Awarded US Government Contract for Influenza Pandemic Preparedness and Response
7. Avery-Landsteiner Prize for Immunology Awarded to Alain Fischer of Paris, France, by German Society for Immunology
8. Trellis Bioscience Awarded SBIR Grant to Advance CMV Program
9. Astrix Technology Group Awarded Department of Homeland Security BioWatch Laboratory Staffing Contract
10. Ekahau - A Preferred Provider of Real-Time Location Solutions - Is Awarded an Agreement with the Premier Healthcare Alliance
11. Elusys Awarded Additional $50.2 Million Under An Exisiting U.S. Government Contract To Support Final Stages Of Development Of ETI-204, For Treatment Of Inhalational Anthrax
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/22/2017)... ... February 22, 2017 , ... LabRoots , the leading ... the world, is pleased to announce the 2nd annual Precision Medicine Virtual Conference. ... online-only conference focused on the development and advancements in precision medicine. , Precision ...
(Date:2/22/2017)... Feb. 22, 2017 Origin (Origin Agritech, LLC, a subsidiary ... seed provider, and Arcadia (Arcadia Biosciences, Inc., ... and commercializes agricultural productivity traits and nutritional products, today announced their ... product developed in China to ... ...
(Date:2/22/2017)... (PRWEB) , ... February 22, 2017 , ... ... announced the addition of Tom Perkins as European director. Operating from Pennside’s Zurich ... to Pennside. , Perkins joins Pennside after more than a decade with ...
(Date:2/21/2017)... 2017 Synthetic Biologics, Inc. (NYSE MKT: SYN), ... to protect and restore the health of patients, intends to report ... 2016 on Thursday, March 2, 2017, and to host a conference ... for the call is as follows: U.S. (toll free): ... ...
Breaking Biology Technology:
(Date:2/7/2017)... 2017 Zimmer Biomet Holdings, Inc. (NYSE and ... present at the LEERINK Partners 6th Annual Global Healthcare ... Wednesday, February 15, 2017 at 10 a.m. Eastern Time. ... can be accessed at http://wsw.com/webcast/leerink28/zbh .  The webcast ... Zimmer Biomet,s Investor Relations website at http://investor.zimmerbiomet.com . ...
(Date:2/3/2017)... ANTONIO , Feb. 3, 2017  Texas Biomedical Research ... Dr. Larry Schlesinger as the Institute,s new ... Texas Biomed effective May 31, 2017. He is currently the ... Director of the Center for Microbial Interface Biology at Ohio ... Schlesinger as the new President and CEO of Texas Biomed," ...
(Date:2/2/2017)... 2, 2017  EyeLock LLC, a market leader of ... paper " What You Should Know About Biometrics in ... user authenticity is a growing concern. In traditional schemes, ... However, traditional authentication schemes such as username/password suffer from ... authentication offers an elegant solution to the problem of ...
Breaking Biology News(10 mins):